Aquestive Therapeutics

(NASDAQ) AQST

Current Price$4.17

Market Cap$539.40M

Since IPO (2018)-73%

5 Year+30%

1 Year+56%

1 Month+6%

Aquestive Therapeutics Financials at a Glance

Market Cap

$539.40M

Revenue (TTM)

$44.55M

Net Income (TTM)

$83.78M

EPS (TTM)

$-0.78

P/E Ratio

-5.58

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$4.17

Volume

63,140

Open

$4.33

Price

$4.17

Volume

63,140

Open

$4.33

Previous Close

$4.17

Daily Range

$4.17 - $4.39

52-Week Range

$2.12 - $7.55

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$4.17

Volume

63,140

Open

$4.33

Previous Close

$4.17

Daily Range

$4.17 - $4.39

52-Week Range

$2.12 - $7.55

AQST News

A medical professional using a microscope

Why Aquestive Therapeutics Dived by 29% Today

Eric VolkmanDec 21, 2021

These 2 Pharma Stocks Could Be Top Stocks in 2020

Amar KhatriJul 6, 2020

AQST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aquestive Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

147

CEO

Daniel Barber, MBA

Website

www.aquestive.com

Headquarters

Warren, NJ 07059, US

AQST Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

Return on Capital

-63%

Return on Assets

-52%

Earnings Yield

-17.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$539.40M

Shares Outstanding

124.28M

Volume

63.14K

Avg. Volume

1.69M

Financials (TTM)

Gross Profit

$25.99M

Operating Income

$71.05M

EBITDA

$70.49M

Operating Cash Flow

$52.43M

Capital Expenditure

$562.00K

Free Cash Flow

$52.99M

Cash & ST Invst.

$121.17M

Total Debt

$131.44M

Aquestive Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$13.02M

+9.7%

Gross Profit

$7.18M

-2.3%

Gross Margin

55.16%

N/A

Market Cap

$539.40M

N/A

Market Cap/Employee

$3.80M

N/A

Employees

142

N/A

Net Income

$31.86M

-86.8%

EBITDA

$28.71M

-126.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$10.28M

-130.6%

Accounts Receivable

$17.76M

+141.9%

Inventory

$6.17M

+2.1%

Long Term Debt

$119.82M

+219.8%

Short Term Debt

$11.63M

+2068.8%

Return on Assets

-52.23%

N/A

Return on Invested Capital

-62.98%

N/A

Free Cash Flow

$8.55M

-31.5%

Operating Cash Flow

$8.47M

-30.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OFIXOrthofix Medical Inc.

OFIXOrthofix Medical Inc.$12.18+4.37%

ARVNArvinas, Inc.

ARVNArvinas, Inc.$9.57-0.93%

EBSEmergent BioSolutions Inc.

EBSEmergent BioSolutions Inc.$8.50-5.03%

ESPREsperion Therapeutics, Inc.

ESPREsperion Therapeutics, Inc.$3.13+0.00%

SNDLSNDL Inc.

SNDLSNDL Inc.$1.41-1.40%

SIGASIGA Technologies, Inc.

SIGASIGA Technologies, Inc.$4.45-2.20%

AVXLAnavex Life Sciences Corp.

AVXLAnavex Life Sciences Corp.$3.06-5.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

QUBTQuantum Computing

QUBTQuantum Computing$11.78+0.16%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.96-0.05%

NOKNokia

NOKNokia$13.17-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.96-0.03%

WOKWork Medical Technology Group Ltd

WOKWork Medical Technology Group Ltd$6.66+0.70%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.31+0.03%

IRENIren

IRENIren$56.56+0.03%

Questions About AQST

What is the current price of Aquestive Therapeutics?

Aquestive Therapeutics is trading at $4.17 per share.

What is the 52-week range for Aquestive Therapeutics?

Over the past 52 weeks, Aquestive Therapeutics has traded between $2.12 and $7.55.

How much debt does Aquestive Therapeutics have?

As of the most recent reporting period, Aquestive Therapeutics reported total debt of $131.44M.

How much cash does Aquestive Therapeutics have on hand?

Aquestive Therapeutics reported $121.17M in cash and cash equivalents in its most recent financial results.

What is Aquestive Therapeutics’s dividend yield?

Aquestive Therapeutics does not currently have a dividend yield.

Aquestive Therapeutics

Aquestive Therapeutics Financials at a Glance

AQST News

Why Aquestive Therapeutics Dived by 29% Today

These 2 Pharma Stocks Could Be Top Stocks in 2020

AQST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aquestive Therapeutics

AQST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aquestive Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AQST

What is the current price of Aquestive Therapeutics?

What is the 52-week range for Aquestive Therapeutics?

How much debt does Aquestive Therapeutics have?

How much cash does Aquestive Therapeutics have on hand?

What is Aquestive Therapeutics’s dividend yield?

Premium Investing Services